Marc A. Alpert - 09 Feb 2026 Form 4 Insider Report for LOEWS CORP (L)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
11 Feb 2026, 16:15:28 UTC
Prior SEC filing
06 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas H. Watson by power of attorney for Marc A. Alpert

Key filing fact

Marc A. Alpert filed Form 4 for LOEWS CORP (L) on 11 Feb 2026.

Key facts

  • This page summarizes Marc A. Alpert's Form 4 filing for LOEWS CORP (L).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 11 Feb 2026, 16:15.

Change

  • Previous filing in this sequence was filed on 06 Feb 2026.
  • Current net transaction value: -$383,983.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001680117 Primary reporting owner

Alpert Marc A

Relationship
Sr. VP, Gen. Coun. & Secy.
Address
C/O LOEWS CORPORATION, 9 WEST 57TH STREET, NEW YORK
Signature
/s/ Thomas H. Watson by power of attorney for Marc A. Alpert
Signature date
11 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

L transaction

Common Stock

Sale

Transaction value
$315,860
Shares
-2,878
Change %
-15%
Price
$109.75
Shares after
16,942
Date
10 Feb 2026
Ownership
Direct
Footnotes
F1
L transaction

Common Stock

Sale

Transaction value
$68,123
Shares
-617
Change %
-3.6%
Price
$110.41
Shares after
16,325
Date
10 Feb 2026
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

L transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+9,502
Change %
Price
$0.000000
Shares after
9,502
Date
09 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,502
Exercise price
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents the weighted average price of multiple transactions with a range of prices between $109.21 and $110.19. The Reporting Person, upon request by the Commission Staff, the Issuer or security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold.

Footnote F2

Represents the weighted average price of multiple transactions with a range of prices between $110.22 and $111.05. The Reporting Person, upon request by the Commission Staff, the Issuer or security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold.

Footnote F3

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Footnote F4

The RSUs were awarded to the Reporting Person on February 17, 2025 subject to the Issuer achieving a pre-determined level of performance based income ("PBI Metric") for 2025. The Issuer's Compensation Committee determined that the Issuer achieved the PBI Metric on February 9, 2026. 50% of the RSUs vest on February 17, 2027 and the remaining 50% vest on February 17, 2028. Shares of the Issuer's common stock will be delivered to the Reporting Person within 30 days after vesting, subject to any election to defer delivery of shares by the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .